Valion Bio Inc. (VBIO) Stock Price

0.31 ▲ +0.032 (+11.51%)
Open: 0.2976 Vol: 3.35M Day's range: 0.2563 - 0.3613 Jul 31, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VBIO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY NEUTRAL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.30▲ 0.29▲ 0.31▼ 0.29▲ 0.42▼
MA10 0.30▲ 0.30▲ 0.30▲ 0.30▲ 0.53▼
MA20 0.30▲ 0.30▲ 0.29▲ 0.40▼ N/A    
MA50 0.30▲ 0.35▼ 0.38▼ 0.56▼ N/A    
MA100 0.36▼ 0.44▼ 0.47▼ N/A     N/A    
MA200 0.46▼ 0.57▼ 0.66▼ N/A     N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▼ 0.005▲ 0.009▲ 0.000▲ N/A    
RSI 50.819▲ 48.922▼ 46.573▼ 31.839▼ N/A    
STOCH 58.135     45.761     63.082     16.485▼ N/A    
WILL %R -56.387     -49.212     -49.212     -77.246▼ N/A    
CCI -2.290     28.398     49.547     -37.922     N/A    
Latest Filters Detected On VBIO
▲ RSI $VBIO RSI(14) Crossed Above 30 Set Alert
▲ MACD $VBIO MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $VBIO Price Crossed Above MA(7) Set Alert
▲ GAP $VBIO Open Gap Up %5 Set Alert
▲ GAP $VBIO Open Gap Up %3 Set Alert
▲ GAP $VBIO Open Gap Up %2 Set Alert
Valion Bio Inc. News
Valion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansion
Monday, July 13, 2026 05:00 PM
Strategic execution across multiple initiatives positions the Entolimod platform to pursue opportunities in government preparedness, domestic biomanufacturing and oncology supportive care SAN ANTONIO, ...
Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures
Thursday, June 11, 2026 04:45 AM
SAN ANTONIO, June 11, 2026 /PRNewswire/ -- Valion Bio, Inc. (Nasdaq: VBIO) ("Valion Bio" or the "Company") (f/k/a Tivic Health Systems, Inc.), a late-stage biopharmaceutical company, confirmed today ...
Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work
Thursday, May 14, 2026 04:12 PM
“Our priorities for the balance of the 2026 year are clear… in the second half, we expect to initiate physician-sponsored studies in neutropenia.” (CEO & Director Handley) “In the third quarter, we ...
VBIO historical stock data
date open high low close volume
31/07/26 0.2976 0.3613 0.2563 0.31 3,345,738
30/07/26 0.2662 0.279 0.2512 0.278 134,321
29/07/26 0.27 0.28 0.2531 0.28 134,977
28/07/26 0.2879 0.2967 0.251 0.2878 148,400
27/07/26 0.2873 0.3069 0.2577 0.2827 236,049
24/07/26 0.2875 0.4289 0.275 0.297 6,166,189
23/07/26 0.277 0.2877 0.2531 0.286 387,451
22/07/26 0.31 0.3208 0.28 0.285 3,076,719
21/07/26 0.35 0.3725 0.3102 0.311 375,377
20/07/26 0.456 0.48 0.3505 0.3611 1,071,560
Quote Details
52wk Low:0.251
52wk High:1.20
Vol:3.35M
Avg Vol(3m):10.9M
1Y Chng:+0.00%
1M Chng:-40.33%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.15M